recombinant human relaxin
Phase 1Active 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pre-Eclampsia
Conditions
Pre-Eclampsia
Trial Timeline
Oct 1, 2006 → —
NCT ID
NCT00333307About recombinant human relaxin
recombinant human relaxin is a phase 1 stage product being developed by Novartis for Pre-Eclampsia. The current trial status is active. This product is registered under clinical trial identifier NCT00333307. Target conditions include Pre-Eclampsia.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00333307 | Phase 1 | Active |
Competing Products
3 competing products in Pre-Eclampsia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Placebo + RLX030 | Novartis | Phase 2 | 52 |
| Sildenafil citrate | Pfizer | Phase 2 | 51 |
| Furosemide | Pacific Biosciences | Phase 3 | 69 |